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The combination of hemophilia and aplastic anemia in the same patient is very uncommon. Hypoplastic anemia has been described in patients with hemophilia, and is usually associated with human parvovirus-B19 infection. 2, 3 We describe the case of a young boy with congenital hemophilia A and acquired severe aplastic anemia (SAA), who was successfully treated by allogeneic bone marrow transplantation (allo-BMT) with his unaffected brother as donor.
The patient was diagnosed with hemophilia A (FVIII 3%, moderate) at 6 months of age when he developed a right knee hemarthrosis and psoas muscle hematoma. His maternal grandfather had hemophilia. The boy started to receive FVIII infusion once a month on average, generally for hemarthroses and bleeding secondary to trauma.
In July 2004, at the age of 6 years, he presented with progressive pancytopenia. Six months later the hemoglobin level was 7 g/dl, the hematocrit 22%, the white blood cell count 1000/ml (absolute neutrophil count 250/ml) and the platelet (PLT) count 23 000/ml. The prothrombin time (PT) was 12 s and partial thromboplastin time (PTT) 85 s. Bone marrow aspiration and biopsy findings were consistent with severe aplastic anemia. The DEB test was negative. He started to receive multiple transfusions of platelets and red blood cells (RBC) because of an increased bleeding tendency (ecchymoses and petechiae). Extensive tests for human parvovirus-B19, hepatitis B and C, rubella, HIV, EBV and CMV were negative. In June 2005, he underwent allo-BMT with his HLA-identical unaffected 5-year-old brother as donor. Before catheter implantation, he was given platelet transfusions (target PLT count 50 000/ml) and 60 U/kg of recombinant human FVIII (rhFVIII) to achieve an initial level of 100%, followed by 30 U/kg every 12 h to maintain a level continuously above 50% for 3 days. The conditioning regimen consisted of cyclophosphamide 50 mg/kg/day from D-5-D-2 and anti-thymoglobulin 5 mg/kg/day from D-3-D-1. Cyclosporine and short-course methotrexate were used for GVHD prophylaxis. The graft consisted of 3. The combination of aplastic anemia and hemophilia is rare. Aplastic anemia has been reported only once in a patient with hemophilia, who had FIX deficiency. 4 Transient hypoplastic anemia has been described in patients with hemophilia, and was related to human parvovirus-B19 infection transmitted by clotting factor concentrates. 2, 3 Our patient developed severe aplastic anemia, but no evidence of a viral etiology was found despite extensive investigations.
The liver is the main source of FVIII. Little is know about the cellular origin of FVIII or its level of expression in different organs, [5] [6] [7] [8] but studies of organ transplant recipients raise the possibility that the spleen, 9 lung 10 and lymphatic tissue 11 may compensate for deficient hepatic FVIII production.
FVIII mRNA levels are high in mouse liver and kidney, and are low but significant in spleen, brain, lung and testis. Bone marrow FVIII mRNA expression has not been evaluated. 12 Our patient's donor was his unaffected brother. Four months after allo-BMT, clotting parameters and the FVIII level remained similar to pretransplant values, suggesting that bone marrow does not make a major contribution to circulating FVIII levels.
The only other reported case of BMT in a patient with hemophilia involved a 26-year-old HIV-infected man with Burkitt-type acute lymphoblastic leukemia. The donor was his homozygous twin brother with hemophilia, who was also HIV-seropositive. The transplant procedure was uneventful but the patient died 18 months later of intracranial relapse. 13 To our knowledge, we report the first allo-BMT procedure involving a patient with hemophilia. The procedure was uneventful, FVIII and platelets being administered at the slightest sign of abnormal bleeding. The FVIII level did not change after transplantation, suggesting that bone marrow does not contribute significantly to FVIII production. M Ostronoff, F Ostronoff, G Campos, S Arruda, C Vaz, R Florencio, R Calixto, AP Souto Maior, A Sucupira, M Domingues and C Tagliari Hematology and BMT Unit, Real-Hospital Portugueˆs, Av. Agamenon Magalha˜es, s/n Recife, Pernambuco, Brazil E-mails: f.ostronoff@uol.com.br; mostronoff@uol.com.br
